CATALOGO DEI PRODOTTI DELLA RICERCA

PIZZOLO, Francesca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.766
EU - Europa 5.757
AS - Asia 3.882
SA - Sud America 547
AF - Africa 46
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 8
Totale 18.018
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.690
GB - Regno Unito 1.912
SG - Singapore 1.490
CN - Cina 1.409
DE - Germania 872
SE - Svezia 562
BR - Brasile 484
FI - Finlandia 443
FR - Francia 438
HK - Hong Kong 425
IT - Italia 425
RU - Federazione Russa 409
IE - Irlanda 387
KR - Corea 157
VN - Vietnam 118
UA - Ucraina 107
BE - Belgio 59
JP - Giappone 58
TR - Turchia 57
CA - Canada 46
NL - Olanda 42
IN - India 28
AR - Argentina 23
BD - Bangladesh 22
AT - Austria 20
ID - Indonesia 20
ZA - Sudafrica 19
IR - Iran 16
PL - Polonia 15
MX - Messico 14
CZ - Repubblica Ceca 12
IL - Israele 12
ES - Italia 11
AU - Australia 9
VE - Venezuela 9
AZ - Azerbaigian 8
CL - Cile 8
CO - Colombia 7
EG - Egitto 7
EC - Ecuador 6
EU - Europa 6
IQ - Iraq 6
SA - Arabia Saudita 6
AE - Emirati Arabi Uniti 5
PE - Perù 5
PK - Pakistan 5
UZ - Uzbekistan 5
HR - Croazia 4
JM - Giamaica 4
JO - Giordania 4
LT - Lituania 4
RO - Romania 4
AL - Albania 3
DK - Danimarca 3
EE - Estonia 3
KG - Kirghizistan 3
LU - Lussemburgo 3
MA - Marocco 3
NP - Nepal 3
NZ - Nuova Zelanda 3
PT - Portogallo 3
TG - Togo 3
TH - Thailandia 3
TN - Tunisia 3
UY - Uruguay 3
AF - Afghanistan, Repubblica islamica di 2
CR - Costa Rica 2
DZ - Algeria 2
HN - Honduras 2
HU - Ungheria 2
KE - Kenya 2
KZ - Kazakistan 2
LB - Libano 2
LV - Lettonia 2
ME - Montenegro 2
MY - Malesia 2
NI - Nicaragua 2
PH - Filippine 2
PS - Palestinian Territory 2
QA - Qatar 2
SI - Slovenia 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BS - Bahamas 1
BY - Bielorussia 1
CH - Svizzera 1
CM - Camerun 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GH - Ghana 1
GP - Guadalupe 1
IM - Isola di Man 1
IS - Islanda 1
Totale 18.006
Salva come PNG Salva come JPEG
Città #
Southend 1.627
Chandler 1.050
Jacksonville 1.029
Dallas 982
Singapore 747
Woodbridge 658
Ann Arbor 549
Ashburn 464
Hong Kong 418
Dublin 385
Houston 283
New York 221
Beijing 191
Verona 170
Wilmington 170
Lawrence 156
Princeton 156
Munich 136
Jinan 121
Helsinki 118
Nanjing 116
Boardman 109
Los Angeles 81
The Dalles 80
Shenyang 77
Lancaster 72
Turku 66
Buffalo 60
Hebei 60
Nürnberg 60
Brussels 59
Tianjin 58
Columbus 57
Tokyo 57
Sindelfingen 56
Dong Ket 54
Milan 50
Redondo Beach 50
Zhengzhou 46
Santa Clara 45
Nanchang 43
Seoul 42
São Paulo 40
Redmond 38
Changsha 37
Haikou 35
Guangzhou 33
Hangzhou 32
Ningbo 31
Seattle 31
Jiaxing 29
Washington 29
Taiyuan 25
Taizhou 24
Toronto 22
Moscow 21
Padova 19
Ho Chi Minh City 17
Norwalk 17
San Francisco 17
London 16
Mestre 16
Boston 15
Chicago 15
Council Bluffs 15
Stockholm 15
Düsseldorf 14
Jakarta 14
Kent 14
Redwood City 14
Rio de Janeiro 14
Fuzhou 13
Hanoi 13
Lanzhou 13
Vienna 13
Boydton 12
Brooklyn 12
Phoenix 12
Rome 12
Dearborn 11
Fairfield 11
Johannesburg 11
Shanghai 11
Amsterdam 10
Campinas 10
Dongguan 10
Falkenstein 9
Falls Church 9
Padua 9
Warsaw 9
Auburn Hills 8
Belo Horizonte 8
Curitiba 8
Frankfurt am Main 8
Montreal 8
Nuremberg 8
Baku 7
Bexley 7
Bologna 7
San Diego 7
Totale 11.974
Salva come PNG Salva come JPEG
Nome #
Multimodality Imaging in Aldosterone-Induced Cardiomyopathy: Early Detection and Prognostic Implications 346
Increased urinary excretion of the epithelial Na channel activator prostasin in patients with primary aldosteronism 264
Altered renal folate handling in hypertensive patients with nephroangiosclerotic damage 246
High plasma apolipoprotein C-III levels predict total and cardiovascular mortality in patients with angiographically defined coronary artery disease. 204
High plasma apolipoprotein C-III levels predict total and cardiovascular mortality in patients with angiographically defined coronary artery disease. 203
Apparent Mineralocorticoid Excess by a Novel Mutation and Epigenetic Modulation by HSD11B2 Promoter Methylation 201
Renovascular disease: effect of ACE gene deletion polymorphism and endovascular revascularization. 173
Abnormal gel flotation caused by contrast media during adrenal vein sampling 171
Novel serum paraoxonase activity assays are associated with coronary artery disease 163
A relative ADAMTS13 deficiency supports the presence of a secondary microangiopathy in COVID 19 162
Global DNA hypomethylation in peripheral blood mononuclear cells as a biomarker of cancer risk 158
ALOX5AP gene variants and risk of coronary artery disease: an angiography-based study 157
Urinary prostasin in normotensive individuals: correlation with the aldosterone to renin ratio and urinary sodium. 156
Global DNA hypomethylation in peripheral blood mononuclear cells as a biomarker of cancer risk 155
Baricitinib restrains the immune dysregulation in patients with severe COVID-19 146
The -1131 T > C and S19W APOA5 gene polymorphisms are associated with high levels of triglycerides and apolipoprotein C-III, but not with coronary artery disease: an angiographic study 145
Genetic risk score from GWA studies is strongly associated with angiographically-defined coronary artery disease, but not with mortalilty in the setting of secondary prevention. 144
Promoter methylation in coagulation F7 gene influences plasma FVII concentrations and relates to coronary artery disease. 143
Urinary protease inhibitor Serpin B3 is higher in women and is further increased in female patients affected by aldosterone producing adenoma 143
High ferritin and low folate increases PBMCs genomic DNA methylation in association with SHMT1-1420TT variant. 142
PON2 Ser311Cys polymorphism is a predictor of total and cardiovascular mortality in patients with angiographically proven coronary artery disease. 140
Interaction between folate and MTHFR1298 A/C polymorphism on Genomic DNA Methylation 138
Interaction between metabolic syndrome and PON 1 polymorphism as a determinant of the risk of coronary artery disease 136
Combined effect of hemostatic gene polymorphisms and the risk of myocardial infarction in patients with advanced coronary atherosclerosis. 136
miRNAs purification and analysis from urinary exosomes. 136
Aldosterone to renin ratio in a primary care setting:the Bussolengo study. 135
Association of endogenous thrombin potential (ETP) with coronary artery disease. An angiography-based study 133
Hyperhomocysteinemia and Mortality after Coronary Artery Bypass Grafting 132
Additive effect of LRP8/APOER2 R952Q variant to APOE epsilon2/epsilon3/epsilon4 genotype in modulating apolipoprotein E concentration and the risk of myocardial infarction: a case-control study. 132
Hyperhomocysteinemia and mortality after coronary artery by-pass grafing. 131
Acquired and genetic determinants of homocysteine in atheromatous renel artery stenosis with mild renal insufficiency 130
The RFC1 80G>A, among Common One-Carbon Polymorphisms, Relates to Survival Rate According to DNA Global Methylation in Primary Liver Cancers 130
Deep vein thrombosis in SARS-CoV-2 pneumonia-affected patients within standard care units: Exploring a submerged portion of the iceberg 130
Homocysteine and atheromatous renal artery stenosis 129
Elevated D-dimer levels are associated with coronary artery disease and cardiovascular death in an angiographically-studied population 128
ApoC-III gene polymorphisms and risk of coronary artery disease 126
Association of endogenous thrombin potential (ETP) with coronary artery disease. an angiography-based study. 126
PON2 Ser311Cys polymorphism is a predictor of total and cardiovascular mortality in patients with angiographically confirmed coronary artery disease. 126
PON2 Ser311Cys polymorphism is a predictor of total and cardiovascular mortality in patients with angiographically confirmed coronary artery disease. 126
NT-proBNP, a useful tool in hypertensive patients undergoing a diagnostic evaluation for primary aldosteronism. 126
Homozygosity for APOCIII variant at position 455 of insulin responsive element promoter region is associated with increased APOC-III levels and risk of coronary artery disease 125
Assessment of SARS-CoV-2 IgG and IgM antibody detection with a lateral flow immunoassay test 125
Low plasma vitamin B-6 concentrations and modulation of coronary artery disease risk. 123
Factor VIII:c Levels in Subjects with the Factor V R2 Polymorphism. 122
Antihypertensive efficacy of spironolactone: what about sex? 121
Apolipoprotein C-III, n-3 Polyunsaturated Fatty Acids, and “Insulin-Resistant” T-455C APOC3 gene polymorphism in heart disease patients: example of gene-diet interaction 121
Serum uric acid, but not rs7442295 polymorphism of SCL2A9 gene, predicts total and cardiovascular mortality in severe coronary artery disease. 120
Aldosterone to renin ratio in a primary care setting: the Bussolengo study 119
Genetic and environmental determinants of hyperhomocysteinemia in subjects with angiographically proven coronary artery disease 119
Association of endogenous thrombin potential (ETP) with coronary artery disease. An angiography-based study. 119
Effects of female sex hormones and contraceptive pill on the diagnostic work-up for primary aldosteronism 119
Polymorphisms in the Hemostatic Pathway Genes and the Risk of Myocardial infarction in Patients with Advanced Coronary Artery Disease. Results from the Verona Heart Project. 118
Apolipoprotein C-III predicts cardiovascular mortality in severe coronary artery disease and is associated with an enhanced plasma thrombin generation 118
Effects Of Female Sex Hormones And Contraceptive Pill On The Diagnostic Work-Up For Primary Aldosteronism 118
Serum uric acid, but not rs7442295 polymorphism of SCL2A9 gene, predicts total and cardiovascular mortality in advanced coronary artery disease. 118
Genetic and eviromental determinants of hyperhomocysteinemia in subjects with corocary artery disease 117
Low circulating vitamin B6 markers of inflammation, and risk of coronary artery disease. 117
High levels of homocysteine are associated with small number of traditional cardiovascular risk factors in patients with similar degree of coronary atherosclerosis. 117
Reduced genomic DNA methylation in peripheral mononuclear cells as an index for the occurrence of cancer disease 117
Hyperhomocysteinemia in relation to total and cardiovascular death after coronary bypass grafting. 116
Low vitamin B6, markers of inflammation, and risk of coronary artery disease. 116
Interaction between smoking and PON2 Ser311 Cys polymorphism as a determinant of the risk of myocardial infarction 114
ApoE epsilon 2/epsilon 3/epsilon 4 polymorphism, ApoC-III/ApoE ratio and metabolic syndrome 112
Determinants of serum ferritin in the metabolic syndrome. 112
Vitamins and epigenetics 112
Epigenetic control of 11-beta-hydroxysteroid dehydrogenase 2 gene promoter is related to human hypertension 111
Interaction between PON 2 polymorphism Ser-Cys and smoking as a determinant of myocardial infarction risk 110
Elevated D-dimer levels are associated with coronary artery disease and cardiovascular death in an angiographically-studied population. 110
CYSTATIN C VERSUS CREATININE IN RENOVASCULAR DISEASE. 109
Apolipoprotein C-III, metabolic syndrome, and risk of coronary artery disease 109
Urinary prostasin: a candidate marker of ENaC activation in humans:study of preliminary feasibility 109
Effects of female sex hormones and contraceptive pill on the diagnostic work-up for primary aldosteronism. 109
Prevalence of body iron excess in the metabolic syndrome. 108
Extensive life-treatening thrombosis in a patient with heparin-induced thrombocytopenia and factor V Leiden mutation 108
Genetic risk score from GWA studies is strongly associated with angiographically-defined coronary artery disease but not with mortality in the setting of secondary prevention 108
Determinants of serum ferritin and prevalence of iron overload in the Metabolic (Insulin Resistance). 107
Epigenetics regulation of HSD11B2 gene by promoter methylation in glucocorticoid-treated patients 107
Apolipoprotein CIII,metabolic syndrome,and risk of coronary artery disease. 106
Delation variant of ACE gene is associated with atherosclerotic renal stenosis not with coronary artery disease 106
Carriership of apolipoprotein CIII –455C gene variant strongly increases the coronary artery disease risk associated with the metabolic sindrome. 106
Folic acid effects on s-adenosylmethionine, s-adenosylhomocysteine, and DNA methylation in patients with intermediate hyperhomocysteinemia. 106
Impaired activity of 11--hydroxysteroid dehydrogenase type 2 in glucocorticoid treated and in hypertensive patients from primary and tertiary care. 105
Female urinary proteomics: New insight into exogenous and physiological hormone-dependent changes. 105
Primary hyperaldosteronism: a frequent cause of residual hypertension after successful endovascular treatment of renal artery disease 104
La diagnostica di laboratorio nella sindrome da apparente eccesso di mineralcorticoidi [The laboratory diagnosis of apparent mineralocorticoid excess (AME)] 104
Acute haemolysis by cold antibody during SARS-CoV-2 infection in a patient with Evans syndrome: a case report and literature review 104
Aldosterone to Renin Ratio (ARR) in Clinical use, with Reference to the Primary Care Setting: ARR to Whom, When, How, What for? 103
Serum uric acid, but not rs7442295 polymorphism of SCL2A9 gene, predicts total and cardiovascular mortality in severe coronary artery disease. 103
Urinary cortisol to cortisone metabolites ratio in prednisone-treated and spontaneously hypertensive patients 102
Primary aldosteronism is a frequent cause of poor blood pressure control despite techically successful endovascular treatment of renal artery stenosis 101
MTHFR C677T genotype-specific thresold values of folate status able to induce mild hyperhomocysteinemia. 101
Epigenetic control of hydroxysteroid (11-beta) dehydrogenase 2 gene is related to human hypertension 101
High Plasma Levels of Activated Factor VII-Antithrombin Complex Point to Increased Tissue Factor Expression in Patients with SARS-CoV-2 Pneumonia: A Potential Link with COVID-19 Prothrombotic Diathesis 100
G20210A prothrombin gene polymorphism and prothrombin activity in subjects with or without angiographically documented coronary artery disease. 100
FADS genotypes and desaturase activity estimated by the ratio of arachidonic acid to linoleic acid are associated with inflammation and coronary artery disease 100
DIFFERENT IMPACT OF DELETION POLYMORPHISM OF GENE ON THE RISK OF RENAL AND CORONARY ARTERY DISEASE 99
Factor VII polymorphisms and the risk of myocardial infarction in coronary atherosclerosis. 99
Fully automated chemiluminescence vs RIA aldosterone assay in primary aldosteronism work-up 99
Stima della prevalenza dell’ipertensione arteriosa e di altri fattori di rischio cardiovascolare nella popolazione generale residente nell’ASL22 della Regione Veneto. 98
Effects of female sex hormones and contraceptive pill on the diagnostic work-up for primary aldosteronism 98
Totale 12.858
Salva come PNG Salva come JPEG
Categoria #
all - tutte 64.523
article - articoli 39.617
book - libri 0
conference - conferenze 23.827
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.079
Totale 129.046
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021931 0 0 0 150 151 135 31 119 95 24 147 79
2021/20221.168 70 300 15 117 64 41 15 60 54 38 112 282
2022/20232.922 197 315 250 504 295 659 23 206 352 17 66 38
2023/20241.601 62 101 122 137 170 354 46 116 21 57 230 185
2024/20253.452 187 228 130 599 130 121 211 106 506 226 312 696
2025/20262.430 721 561 1.042 106 0 0 0 0 0 0 0 0
Totale 18.161